microlitre

(redirected from microliter)
Also found in: Thesaurus, Medical, Legal, Acronyms, Encyclopedia.

microlitre

(ˈmaɪkrəʊˈliːtə) or

microliter

n
(Units) one millionth of a litre
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
References in periodicals archive ?
Good correlation between fluorescent optical method and IRM has been reported for platelet counts up to 30,000 per microliter of blood.4
"We have developed a microfluidic biosensor based on a differential immuno-capture electrical cell counting technology to enumerate specific cells in 20 minutes using 10 microliters of blood." (There are about 50 microliters in a drop of blood).
Through the addition of MicroLiter, which provides products for use with autosamplers, Wheaton delivers on its strategy to boost its position in chemical analysis products, the buyer's president, Wayne Brinster, said.
--a significant increase in the total number of platelets -170 in the surviving controls to 380 thousand cells/ microliter at 23 days (p<0.001).
Couples in which both partners were 18 or older were eligible to participate if one partner was HIV-1 seronegative and the other had tested positive for HIV-1 and HSV-2, had a CD4 count of 250 per microliter or higher, did not have AIDS and was not receiving antiretroviral therapy.
The KD Scientific Model KDS 310 Nano Pump is used exclusively with micro syringes from 0.5 to 250 microliters. Small size, remote control and a rugged mounting arm make it ideal for use with micro-manipulators, stereotaxic frames and other clamping devices.
of Vancouver, wash., designed its PS 80 variable-stroke ceramic piston pump to deliver microliter doses of fluid with more than 99 percent accuracy.
The new system offers a less painful blood glucose testing, requiring such a tiny drop of blood (1 microliter).
The patients have been diagnosed with persistent or chronic ITP, and have blood platelet counts consistently below 30,000 per microliter of blood.
In the fourth quarter of 2015, the company plans to submit the NDA to the US FDA and to request accelerated approval for the treatment of patients with intermediate and high-risk myelofibrosis with low platelet counts of less than 50,000 per microliter. Myelofibrosis is a rare and serious chronic blood cancer that can affect patients of all ages with a median age of 65 years, with an estimated prevalence in the US of approximately 18,000 patients.